Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SoftOx Solutions AS ( (DE:6FV) ) just unveiled an update.
SoftOx Solutions AS has secured a financing facility with Long State Investments Limited, providing up to NOK 50 million over 24 months, with an option to extend to NOK 80 million over 36 months. This agreement offers SoftOx financial flexibility to support its clinical trials and growth, allowing the company to raise capital as needed while maintaining control over timing and pricing. The facility ensures a stable financial platform for SoftOx’s development without restricting other financing options.
More about SoftOx Solutions AS
SoftOx Solutions AS is a clinical-stage pharmaceutical company listed on Euronext Growth Oslo, specializing in developing pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The company’s technology is developed in collaboration with leading Nordic research institutes.
YTD Price Performance: 614.29%
Average Trading Volume: 22,026,287
Current Market Cap: NOK235.2M
Find detailed analytics on 6FV stock on TipRanks’ Stock Analysis page.